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doi:10.1016/j.ejvs.2008.03.015Abstract Background: Cellulitis, often recurrent is a common complication of severe chronic
venous disease (CVD) when dermatitis or ulcer is present. The skin breakdown obviously provides
easy entry for bacteria but other factors such as oedemaand lymphatic dysfunction likely play a role
in pathogenesis as well. An iliac obstructive lesion is commonly present and correction with stent(s)
often heals dermatitis/ulcer and relieves cellulitis. The current manuscript focuses on a relatively
infrequent ‘‘spontaneous’’ variety of cellulitis which also occurs in obstructive venous disease in
theabsenceofovert skinbreakdown. Stenting results areofparticular interest in this subsetbecause
its therapeutic efficacy can be related to factors other than healing of dermatitis/ulceration (portal
of entry).
Material andmethods: One thousand and nine limbs underwent iliac vein stenting for symptomatic
CVD over a 7 year period; 29 limbs thatwere stented to treat spontaneous recurrent cellulitis of two
or more prior attacks and 16 additional limbs with only one prior episode (stented for other indica-
tions)areanalysed.Eighty twopercentof the limbshadobvious swellingand the remainderhadnone
at the time of stenting when cellulitis was inactive. Iliac vein outflow obstruction was found by
intravascular ultrasound (IVUS) and all limbs were stented.
Results: Median age was 54 and male to female ratio 1:2. Aetiology of iliac obstruction was post-
thrombotic in33%andnon-thrombotic in67%.Preoperatively, lymphaticabnormalitieswerepresent
in 17 (38%) of the limbs: no activity in 7, delayed flow in 8 and pooling of isotope in the lower leg in 2
limbs. Swelling and pain improved significantly after stent placement. Cumulative freedom from
recurrent attacks of cellulitis was 76% at 3 years.
Conclusion: Iliac vein outflow obstruction may underlie CVD limbs afflicted with cellulitis. IVUS
examination is recommended if cellulitis is recurrent and conventional therapy had failed. Correc-
tion of outflow obstruction by venous stent placement appears to yield moderate freedom from
repeat infections in the near term.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.1020 River Oaks Dr., Ste. 420 Flowood, MS 39232, USA. Tel.: þ601 939 4230.
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Spontaneous Onset of Bacterial Cellulitis in Lower Limbs 607Bacterial cellulitis is a common complication of chronic
venous disease (CVD) when dermatitis or open ulcers are
present. The problem can become recurrent posing a diffi-
cult management problem. Even though skin breakdown
allowing bacterial entry is the obvious initiating event,
factors that favour bacterial growth and compromise local
host defences1 as in lymphoedema are likely present in CVD
as well. This is particularly evident in a relatively rare type
soft tissue infection that occurs in CVD in the absence of
skin breakdown i.e., there is no obvious entry point for
the infection such as an ulcer, eczema, traumatic skin abra-
sion or interdigital skin fissure2,3 The term ‘spontaneous
bacterial cellulitis’ is used in this manuscript to denote
this type of infection. The clinical picture is that of a CVD
patient with chronic leg swelling (occasionally no prior
swelling) that experiences sudden onset of pain, redness
and increased (or new) swelling of the leg, usually below
the knee. Other causes of similar clinical presentation
such as superficial thrombophlebitis and deep venous
thrombosis are ruled out by clinical examination and duplex
examination. The cellulitis rarely responds and often prog-
resses on anti-inflammatory regimen alone. Institution of
antibiotics with gram positive coverage usually results in
quick clinical resolution in a matter of three to four days
in most cases. After resolution of the inflammation, swell-
ing often persists and becomes chronic. There is a predilec-
tion for recurrent attacks with progressive worsening of
swelling and pain. The affected limb is chronically
erythematous, sore to touch and presents the clinical pic-
ture of chronic low grade cellulitis. The clinical complex
is readily recognisable as a distinct clinical entity in CVD
patients and is identical in all other respects to the celluli-
tis seen in the more common variety that occurs in the
presence of dermatitis or stasis ulcer.
Spontaneous cellulitis in CVD is analogous to that found in
lymphoedema with some differences. The latter is variously
referred to as ‘erysipelas’ or dermatolymphangioadenitis
(DLA)1 and also has a complex pathogenesis. Swelling and
infection are confined to the subcutaneous tissues in lym-
phoedema. In CVD, both swelling and the infection are
more diffuse involving both the superficial and deep com-
partments, often evident on CT or MR imaging. Though
‘soft tissue infection’ would be more precise, the term
‘cellulitis’ has become well established by common usage
when referring to infections associated with CVD.
Chronic long term antibiotic therapy1,4,5 is the standard
treatment recommendation when cellulitis becomes recur-
rent. In the course of treating obstructive venous disease
with stent placement, we have become aware that celluli-
tis/recurrent cellulitis are a feature of outflow obstruction
and its correction by stent placement is often curative.
Though resolution of cellulitis is obtained both in spontane-
ous cellulitis and in the more common variety with derma-
titis and stasis ulcer, the results are of particular interest in
‘‘spontaneous’’ variety, because stenting often results in
concurrent healing of dermatitis/ulceration presenting
the former. The manuscript focuses on the relatively infre-
quent spontaneous variety of cellulitis in CVD because
efficacy of stenting on host factors uncoupled from portal
of entry factors can be ascertained; but the implications
are probably relevant as well for the larger group of CVD
patients at risk from cellulitis.Patients and Study Design
A total of 1,009 limbs were treated with iliac vein stenting to
correct deep venous obstruction from 1999 to 2006 for relief
of CVD symptoms not responsive to conventional therapy.
Among these, a history of prior cellulitis was recorded in 259
limbs (26%), but venous dermatitis or ulcers were present in
214 limbs and were excluded from analysis. Recurrent
spontaneous cellulitis with two or more episodes in the
absence of skin changes was the primary indication for
stenting in 29 limbs (20 with 2e4 episodes and 9 with five
or more episodes). An additional group of 16 limbs had only
one documented episode of spontaneous cellulitis and were
stented not for this reason but for other features of CVD such
as severe venous pain (VAS >5/10) or swelling. These limbs
too are included in the analysis but the outcome is separately
tabulated. Imputation of therapeutic effect is less certain
with the single episode subset because not all first episodes
become recurrent i.e. absence of infection after stenting
could be either because of the stent or natural history.
However, clinical features and failure of venous stenting to
prevent cellulitis in the latter subset are relevant.
Clinical Assessment
The venous clinical severity scoring system6 was used as
a template in clinical assessment. A detailed venous history
included details of cellulitis such as number of episodes, first
and last attack dates. Chronic limb pain when cellulites was
not active was scored on a visual analogue scale7 (VAS) 0 to
10. Chronic limb oedema was assessed when cellulitis was
not active and was graded from 0 to 3 (Gr. 0- none; Gr. 1- pit-
ting; Gr. 2 ankle oedema; Gr. 3- gross). Limbs were examined
for a portal of entry for the infection including skin eczema/
dermatitis and ulcers of various types (traumatic, fungal and
venous) and if found are not included in this analysis.
The investigative protocol has been described in detail
elsewhere.8 Briefly, patients underwent a detailed set of
venous investigations including duplex, ambulatory venous
pressure measurement, Air Plethysmography, and Arm/
Foot pressure measurement. An isotope lymphangiogram,
ascending and transfemoral venograms with femoral
exercise pressure measurements were routinely obtained.
Intravascular Ultrasound examination (IVUS) was the key
diagnostic investigation9 as preoperative investigative
parameters were only about 50% sensitive for iliac venous
obstruction.8 Iliac vein stent placement was carried out
at the same sitting under IVUS guidance.
Stent Placement
Selection of patients for stent placement was based on
severity of symptoms. Generally only patients who had
failed conservative therapy of compression stockings and
appropriate antibiotic therapy for spontaneous cellulitis
were considered. Patients with recurrent episodes not
responsive to such measures were candidates. Some
patients who had only one attack of spontaneous cellulitis
were stented primarily because of severity of other
symptoms of venous disease such as severe limb pain (VAS
>5/10) or severe limb swelling. Some CEAP class 0e2 limbs
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Figure 1 Cumulative complete relief of limb swelling after
iliac vein stent placement in patients presenting with cellulitis.
608 S. Raju et al.were stented because of pain and/or recurrent cellulitis
even though swelling was absent at the time of stenting.
Technical details and results of stenting for outflow
obstruction have been published in detail elsewhere.9e15
The common and external iliac veins and the adjoining caval
and femoral segments were the focus of stent treatment. In
general, stenotic lesions that showed a 60% or greater reduc-
tion in lumen area per IVUS examinationwere correctedwith
stents. Percutaneous laser or radiofrequency ablation of the
proximal great saphenous vein in the thigh was attempted
concurrently16 in five of eight limbs where saphenofemoral
reflux was present (2/5 failed to ablate and underwent strip-
ping later). In the other three, concurrent saphenous
ablation was not performed because saphenous access
failed (1), the stenting was a complex prolonged procedure
involving recanalisation (1) or for unclear reasons (1). Deep
reflux when present was not corrected in this series. Below
knee varicosities were also not treated as they were not
considered to be the dominant factor in onset of cellulitis.
The stenting procedure is percutaneous and is carried out
on an outpatient basis (23 hr admission). Most patients are
maintained on daily ASA (81 mg) except in cases of thrombo-
philia or recurrent deep vein thromboses when Warfarin is
instituted. Patients were instructed to continue preopera-
tive leg compression they were using for a month after stent
placement and were encouraged to abandon compression
afterwards if tolerated. Compliance with leg compression
regimens is very low in the patient population covered.17
Data Analysis
Clinical features, operative details and follow up data were
contemporaneously entered into a time stamped electronics
medical records program. Current material is extracted from
this database. Commercially available statistical program
(Graph Pad Prism for Windows [version 3.0], GraphPad
Software, San Diego, CA) was used for statistical analysis.
Non-parametric Wilcoxon rank test for unpaired and paired
data and chi square were used to analyze groups as
appropriate. Cumulative curves using the Kaplan-Meier
method were used to analyze clinical outcome. Log rank
test was utilized to assess significance between cumulative
curves. A p-value of less than 0.05was considered significant.
Results
According to CEAP method18 of classifying CVD, the limbs
were recorded as follows: C 0 (normal) e 1 (2%); C 1
(spiders) e 0 (0%); C 2 (varices) e 7 (16%); C 3 (swelling)
e 36 (82%). C 4, 5, and 6, which involve skin breakdown
of various types have been excluded from the material.
Male to Female ratio was 1:2. The median age was 54 (range
18e87). The left limb was involved in 49%, right in 51%.
Aetiology of venous obstruction was post-thrombotic in
33% and non-thrombotic (‘primary’) in 67%. The incidence
of non-insulin dependent diabetes was 11%, and insulin
dependent diabetes was 4%.
Preoperative median venous clinical severity score was 6
(range 0e11) among the 45 limbs. Superficial reflux was
present in 18 limbs (40%), which can be grouped according
to the lead segment involved as follows: proximal GSVreflux 8, Short saphenous reflux 5, distal GSV reflux and calf
varices 5; various combinations of these were present in 6
limbs. In 9 (20%) limbs, deep reflux occurred, all except one
in combination with superficial reflux; Deep reflux was axial
in 8 limbs. Isotope lymphangiography showed no activity in
regional nodes in 7 (16%), and delayed activity in 8 (18%)
limbs; pooling or stasis of the isotope in the lower leg was
observed in 2 (4%) limbs. Lymphangiogram was normal in 28
(62%) limbs. Preoperative transfemoral venography with
simultaneous femoral exercise pressure measurement
suggested iliac venous obstruction in 23/45 limbs.
Thirty day mortality of venous stenting was null and
morbidity was minor, consisting of back or limb pain easily
controlled with analgesics. All stents in this series remained
patent during the observation period.
Swelling improved significantly after stent placement,
from preoperative median grade 3 (range 1e3) to post-
operative grade 1 (range 1e3) (p< 0.0006). Eight limbs had
no chronic swelling preoperatively though present at the
time of active infection. Cumulative complete relief of
swelling in the remaining 37 limbs is shown in Fig. 1.
Chronic limb pain (when cellulitis was not active)
decreased significantly, from preoperative median VAS of
2 (range 0e8) to postoperative VAS of 0 (range 0e6)
(p< 0.0006). Cumulative freedom from cellulitis for the
two subsets (single or 2 attacks) and for the entire group
as a whole is shown in Fig. 2. There was no statistical differ-
ence between the curves for the subsets (Log Rank Test,
pZ 0.07). Stent placement failed to prevent onset of
recurrent cellulitis in 10 patients. Though censored after
the first postoperative attack, all have been followed for
median 4years (range 2e7 years); 2 have had more than
one postoperative attack, all others single episodes. Instent
restenoses (>50%) have been identified in 2/10 on IVUS
examination (pending in others).
Discussion
Twenty six percent of limbs undergoing venous stenting to
relieve obstruction in our centre had a prior episode of
cellulitis; most had overt venous skin breakdown. The
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Figure 2 Cumulative freedom from limb cellulitis after stent
placement to correct venous outflow obstruction. There is no
difference between the subsets.
Spontaneous Onset of Bacterial Cellulitis in Lower Limbs 609spontaneous variety where there is no obvious skin
breakdown occurred in 5% of stented limbs; the disease
was recurrent in over half (3%) of these. Basic work in
clinical pathology of bacterial cellulitis specific to CVD is
sparse;4,19e21 many details discussed herein are necessarily
conjectural or extrapolated from work on lymphoedema.
There is general agreement that the dermal barrier19,22 is
compromised in CVD but it is not clear if overt skin break-
down is necessary for bacterial invasion or if it can occur
through intact but diseased (CVD) skin including hair
follicles and sweat glands. Bacterial invasion from append-
ages of axillary skin which is different in structure from that
of lower limb skin does appear to occur.23 An obvious portal
of entry is not always evident in erysipelas of lymphoe-
dema. We speculate that bacterial invasion occurs in
spontaneous cellulitis of CVD through scratching, invisible
micro abrasions or passage through grossly intact skin
because of microscopic damage to the dermal barrier
from venous disease. Embolic seeding is unlikely but cannot
be strictly excluded. Patients often point to a localized
area of the limb (with intact skin) where the inflammatory
process started before spreading.
In addition to the compromised dermal barrier, the onset
and spread of infection may be related to one or more of
the following associated with venous stasis: limb swelling
providing the substrate for bacterial growth and lymphatic
dysfunction. Recurrent cellulitis may damage existing
lymphatics perpetuating and exacerbating the vicious
cycle.1,15,24 Decreased regional immunity has been postu-
lated in the presence of post-mastectomy lymphoedema.
Indeed the cellulitis even when associated with obvious
skin breakdown (dermatitis/ulcer) has anomalous features
reminiscent of the immunosuppressed patient. Systemic
signs such as fever, leucocytosis, and left shift are not fre-
quently present even though local signs of inflammation
may be quite severe (spreading erythema and streaks,
increased swelling and pain). Blood cultures are seldom
positive. We examined the clinical records of 15 CVD
patients (7 were later stented and included in currentanalysis) requiring hospitalisation for treatment of sponta-
neous cellulitis. Despite severe local inflammation, fever
was present in only 3/15, leucocytosis was present in only
2/15 and blood culture was positive in only one 93 year
old patient. All responded to antibiotics (Penicillin/amoxy-
cillin in 10, vancomycin in 1, cephalosporins in 3 and
ciprofloxacin in 1) with a median hospital stay of 4 days
(range 2e9). Rapid clinical resolution is the rule with
gram positive coverage. In a minority, perhaps in about
10%, other organisms may be involved requiring broader
antibiotic coverage. The rapid clinical resolution with
antibiotics rules out many other conditions that may resem-
ble cellulitis in certain clinical features.25e27
Limb swelling is often but not always present in affected
limbs during quiescent interludes when cellulitis is not
active (8/45 limbs in this series). Other features of CVD can
be usually elicited in such cases on careful history and
examination. Venous outflow obstruction should be consid-
ered when an obvious cause for the infection is not
apparent.1,21 Lymphatic dysfunction can be demonstrated
in about a third of CVD cases28,29 and maybe reversible
when the underlying venous insufficiency is corrected.30
Postoperative lymphangiography was not routinely
performed in the current series and therefore relevant
data is not available.
Correction of venous outflow obstruction in the iliac
vein and adjacent segments afforded relief from recurrent
cellulitis in the majority of cases in the current series.
Complete relief of swelling was desirable but a partial
reduction was helpful in gaining relief from recurrent
infections in many cases. The relationship between
swelling and infection has been inconsistent5 probably
because swelling is not the only factor in clinical pathol-
ogy. We assume that integrity of the barrier function of
the skin is restored or improved after successful stenting;
gross wound healing is certainly restored in chronic ulcer
cases after venous stenting. Recurrence of cellulitis after
stenting should prompt examination for stent malfunction
(IVUS).
The role of iliac outflow obstruction in CVD in general31
and in ‘primary’ disease in particular8 is underestimated.
IVUS examination of the iliac veins and stenting of obstruc-
tive lesions found should be considered in patients presenting
with cellulitis associated with chronic venous disease. Iliac
vein stenting is a low risk percutaneous procedure. Long
term (6 year) cumulative stent patency is remarkable at
100% in non-thrombotic disease and only slightly less in
post-thrombotic disease.10 Clinical benefit tracks the high
patency. In combined obstruction/reflux outcome is good
after stenting even when the reflux component is left
uncorrected.8 This mode of therapy may offer a more direct
solution to the problem than chronic antibiotic ther-
apy1,4,5,7,20,24 or other conservative measures7,18,24,32,33
that require a high degree of patient compliance. The latter
tend to have poor patient acceptance.17
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